Loading clinical trials...
Loading clinical trials...
Efficacy and Safety Comparison of Epiduo Gel Associated With Lymecycline 300 mg Capsules Versus Epiduo Vehicle Gel Associated With Lymecycline 300 mg Capsules in the Treatment of Moderate to Severe Acne Vulgaris
Conditions
Interventions
Adapalene/ BPO gel with Lymecycline capsules
Adapalene/ BPO vehicle gel with Lymecycline capsules
Locations
28
Australia
Galderma Investigator site
Canberra, Australia
Galderma Investigator site
Kogarah, Australia
Galderma Investigator site
Melbourne, Australia
Galderma Investigator site
Sydney, Australia
Galderma Investigator site
Brussels, Belgium
Galderma Investigator site
Ghent, Belgium
Start Date
August 1, 2009
Primary Completion Date
April 1, 2010
Completion Date
May 1, 2010
Last Updated
February 18, 2021
NCT07205107
NCT06225570
NCT05891795
NCT06141330
NCT06501560
NCT03883269
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions